FDG-PET is a whole body scan that evaluates glucose cell metabolism. Its main utility is in adult and children oncology. PET scan is useful differentiating benign from malignant neoplasm, selecting the site for biopsy, staging of the malignancy, evaluating response to therapy and distinguishing scar from residual neoplasm. Different studies have concluded that FDG-PET is a useful study in the gyneco-oncological management, especially in endometrial, cervical and ovarian cancer. This work reviews the principal indications of PET in this pathology and also the initial Chilean experience at the Military Hospital of Santiago with a dedicated PET, where we have studied more than 1,500 cases, most of them in cancer patients.
Sierralta C., P., Jofré M., M. J., Massardo V., T., Canessa G., J., González E., P., & Valdebenito B., R. (2007). Utilidad del PET-FDG en patología gineco-oncológica. Revista Chilena de Obstetricia y Ginecologia.